Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is focused on improving the early detection and management of cancer and other chronic diseases through diagnostics telehealth programs. Its lead product, Aristotle, is a mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. The Care Oncology Clinic offers a supervised treatment regimen for people diagnosed with cancer of any type or stage. AVRT is a physician-led, telehealth program for identifying and managing the early warning signs of cancer and chronic disease. Its program includes a comprehensive online health evaluation; bloodtests to measure markers of inflammation and metabolism; an initial physician consultation; regular physician follow-up appointments and interval screening. Its additional cancer diagnostics include ColonSentry and the Prostate Health Index.


TSX:SZLS - Post by User

Comment by 4real4everon Mar 05, 2021 8:57am
107 Views
Post# 32726333

RE:RE:Quick technical analysis of TSX,NASDAQ BIO index and SZLS

RE:RE:Quick technical analysis of TSX,NASDAQ BIO index and SZLS
MarketMoney wrote:

Just keep in mind, Bio sector got 11 red days out of the last 17 trading days
SZLS got 12 red days out of the last 17 trading days

The Bio sector lost 16% ischh during that same period of time
SZLS lost 33% ischh during that same period of time

SZLS is a stock so it will fluctuate more than NASDAQ Bio index which was during that period of time 2x the index fluctuation. 

EXAS got 10 red days out of the last 17 trading days. EXAS lost 21% during that period of time.

SZLS is more volatile than EXAS as volume transaction is way superior with EXAS so more easy to move SZLS up and down with less needed volume.

Hope theses numbers will help to understand that overall markets will affect each stock. When GME got mega short squeeze, the hedge funds had to liquidate long position to cover for their loss.While doing that caused some stock to go down as they were selling huge amount of good stock to obtain the must needed cash to buyback GME shares to cover. So some stock were collateral damage because of the short squeeze on GME. Voila many things to consider when doing an analysis and it's easier to understand and keep fear aside when you see what really going on and not going for the same broken record of blaming CEO for all your problems :-)
 

 

You pumpers, it's always the market's fault when it's red. What you forget to say is that SZLS is supposed to release the biggest and most wonderful product within 2 weeks and the whole market has known it for months. So, the share price should explode or continually rise.
 
And please, stop comparing EXAS to SZLS, it's embarrassing for EXAS.
<< Previous
Bullboard Posts
Next >>